(2025) identified ENO1 as a novel therapeutic target capable of enhancing antitumor immunity and improving clinical outcomes in breast cancer patients (27), indicating that ENO1 may be a promising therapeutic target. The gene discussed is ENO1; the disease is breast carcinoma.